Detalles de la búsqueda
1.
Fostamatinib or Thrombopoietic Receptor Agonists for the Treatment of Chronic Immune Thrombocytopenia in Adult Patients: A Real-World Assessment of Safety, Effectiveness and Cost.
Acta Haematol
; 2023 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37778326
2.
Diagnosis and management of systemic mastocytosis in a community hematology setting.
J Oncol Pharm Pract
; : 10781552231221149, 2023 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38151028
3.
Dermatological Adverse Events in Prostate Cancer Patients Treated with the Androgen Receptor Inhibitor Apalutamide.
J Urol
; 207(5): 1010-1019, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35020444
4.
A real-world study to evaluate the safety and efficacy of three injectable neurokinin-1 receptor antagonist formulations for the prevention of chemotherapy-induced nausea and vomiting in cancer patients.
Support Care Cancer
; 30(8): 6649-6658, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35499619
5.
Development of a repeated-measures predictive model and clinical risk score for mortality in ventilated COVID-19 patients.
Can J Anaesth
; 69(3): 343-352, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34931293
6.
Clinical utility of a prediction tool to differentiate between breast cancer patients at high or low risk of chemotherapy-induced nausea and vomiting.
Support Care Cancer
; 29(12): 7837-7843, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34176018
7.
Low-molecular-weight heparins for the prevention of recurrent venous thromboembolism in patients with cancer: A systematic literature review of efficacy and cost-effectiveness.
J Oncol Pharm Pract
; 25(1): 68-75, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28857713
8.
Patient monitoring programs in oncology pharmacy practice: A survey of oncology pharmacists in Atlantic Canada.
J Oncol Pharm Pract
; 25(4): 891-895, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30080132
9.
Dalteparin or vitamin K antagonists to prevent recurrent venous thromboembolism in cancer patients: a patient-level economic analysis for France and Austria.
Support Care Cancer
; 25(7): 2093-2102, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28204995
10.
A cost-utility analysis of risk model-guided versus physician's choice antiemetic prophylaxis in patients receiving chemotherapy for early-stage breast cancer: a net benefit regression approach.
Support Care Cancer
; 25(8): 2505-2513, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28281050
11.
Choice of study endpoint significantly impacts the results of breast cancer trials evaluating chemotherapy-induced nausea and vomiting.
Breast Cancer Res Treat
; 155(2): 337-44, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26732944
12.
FOLFOX chemotherapy can safely be given to neutropenic patients with early-stage colorectal cancer for higher dose intensity and fewer visits.
Support Care Cancer
; 24(6): 2533-9, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26694717
13.
Measuring the impact of guideline-based antiemetic therapy on nausea and vomiting control in breast cancer patients with multiple risk factors.
Support Care Cancer
; 24(4): 1563-9, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26381427
14.
Abraxane® versus Taxol® for patients with advanced breast cancer: A prospective time and motion analysis from a Chinese health care perspective.
J Oncol Pharm Pract
; 22(2): 205-11, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25316611
15.
Clinico-morphological features of BRAF inhibition-induced proliferative skin lesions in cancer patients.
Cancer
; 121(1): 60-8, 2015 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25186461
16.
Correlation between progression-free survival and overall survival in metastatic breast cancer patients receiving anthracyclines, taxanes, or targeted therapies: a trial-level meta-analysis.
Breast Cancer Res Treat
; 154(3): 591-608, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26596731
17.
Defining optimal control of chemotherapy-induced nausea and vomiting-based on patients' experience.
Support Care Cancer
; 23(11): 3341-59, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26108169
18.
Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine.
Breast Cancer Res Treat
; 147(3): 631-8, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25216762
19.
A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events.
Breast Cancer Res Treat
; 144(3): 615-24, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24638849
20.
Are community pharmacists equipped to ensure the safe use of oral anticancer therapy in the community setting? Results of a cross-country survey of community pharmacists in Canada.
J Oncol Pharm Pract
; 20(1): 29-39, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24103897